TCL Archive Amgen Replaces “Bundling” Contract With Three Separate Contracts For Growth Factors. September 5, 2008
TCL Archive EGFR Inhibitor Shrinks Tumors In Phase I Study of Patients With Treatment-Resistant Mutation May 30, 2014